» Articles » PMID: 34838049

Bone Morphogenetic Protein 2 Inhibits Growth Differentiation Factor 8-induced Cell Signaling Via Upregulation of Gremlin2 Expression in Human Granulosa-lutein Cells

Overview
Publisher Biomed Central
Date 2021 Nov 28
PMID 34838049
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bone morphogenetic protein 2 (BMP2), growth differentiation factor 8 (GDF8) and their functional receptors are expressed in human ovarian follicles, and these two intrafollicular factors play essential roles in regulating follicle development and luteal function. As BMP antagonists, gremlin1 (GREM1) and gremlin2 (GREM2) suppress BMP signaling through blockage of ligand-receptor binding. However, whether BMP2 regulates the expression of GREM1 and GREM2 in follicular development remains to be determined.

Methods: In the present study, we investigated the effect of BMP2 on the expression of GREM1 and GREM2 and the underlying mechanisms in human granulosa-lutein (hGL) cells. An established immortalized human granulosa cell line (SVOG) and primary hGL cells were used as study models. The expression of GREM1 and GREM2 were examined following cell incubation with BMP2 at different concentrations and time courses. The TGF-β type I inhibitors (dorsomorphin, DMH-1 and SB431542) and small interfering RNAs targeting ALK2, ALK3, SMAD2/3, SMAD1/5/8 and SMAD4 were used to investigate the involvement of the SMAD-dependent pathway.

Results: Our results showed that BMP2 significantly increased the expression of GREM2 (but not GREM1) in a dose- and time-dependent manner. Using a dual inhibition approach combining kinase inhibitors and siRNA-mediated knockdown, we found that the BMP2-induced upregulation of GREM2 expression was mediated by the ALK2/3-SMAD1/5-SMAD4 signaling pathway. Moreover, we demonstrated that BMP2 pretreatment significantly attenuated the GDF8-induced phosphorylation of SMAD2 and SMAD3, and this suppressive effect was reversed by knocking down GREM2 expression.

Conclusions: Our findings provide new insight into the molecular mechanisms by which BMP2 modulates the cellular activity induced by GDF8 through the upregulated expression of their antagonist (GREM2).

Citing Articles

GREM2 inactivation increases trabecular bone mass in mice.

Nilsson K, Henning P, Wu J, Sjogren K, Lerner U, Ohlsson C Sci Rep. 2024; 14(1):12967.

PMID: 38839844 PMC: 11153596. DOI: 10.1038/s41598-024-63439-4.


Exploring Tumor-Promoting Qualities of Cancer-Associated Fibroblasts and Innovative Drug Discovery Strategies With Emphasis on Thymoquinone.

Padathpeedika Khalid J, Martin T, Prathap L, Abhimanyu Nisargandha M, Boopathy N, Kishore Kumar M Cureus. 2024; 16(2):e53949.

PMID: 38468988 PMC: 10925941. DOI: 10.7759/cureus.53949.


ID3 mediates BMP2-induced downregulation of ICAM1 expression in human endometiral stromal cells and decidual cells.

Luo J, Wang Y, Chang H, Zhu H, Yang J, Leung P Front Cell Dev Biol. 2023; 11:1090593.

PMID: 36910152 PMC: 9998904. DOI: 10.3389/fcell.2023.1090593.


Expression and Localization of Fas-Associated Factor 1 in Testicular Tissues of Different Ages and Ovaries at Different Reproductive Cycle Phases of .

Wang J, Pan Y, Zhang R, Xu G, Wu R, Zhang W Animals (Basel). 2023; 13(3).

PMID: 36766229 PMC: 9913830. DOI: 10.3390/ani13030340.

References
1.
Wozney J, Rosen V, Celeste A, Mitsock L, Whitters M, Kriz R . Novel regulators of bone formation: molecular clones and activities. Science. 1988; 242(4885):1528-34. DOI: 10.1126/science.3201241. View

2.
McPherron A, Lawler A, Lee S . Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997; 387(6628):83-90. DOI: 10.1038/387083a0. View

3.
McMahon R, Murphy M, Clarkson M, Taal M, Mackenzie H, Godson C . IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta1. J Biol Chem. 2000; 275(14):9901-4. DOI: 10.1074/jbc.275.14.9901. View

4.
Koroglu N, Mathyk B, Tola E, Cetin B, Yuksel I, Dag I . Gremlin-1 and gremlin-2 levels in polycystic ovary syndrome and their clinical correlations. Gynecol Endocrinol. 2019; 35(7):604-607. DOI: 10.1080/09513590.2019.1566452. View

5.
Ikeda Y, Hasegawa A, Tsubamoto H, Wakimoto Y, Kumamoto K, Shibahara H . Effects of gremlin-2 on the transition of primordial follicles during early folliculogenesis in the human ovary. Eur J Obstet Gynecol Reprod Biol. 2016; 203:72-7. DOI: 10.1016/j.ejogrb.2016.05.026. View